KP Tissue Inc.

KP Tissue Inc.

KPTSF
KP Tissue Inc.US flagOther OTC
8.92
USD
+0.07
- -
89.40MMarket Cap
KP Tissue Inc.
KPTSF
(Other OTC)

Recent

price

8.92

P/E

ratio

- -

div

yld

- -

ROIC.AI

2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
- -
0.2
-0.26
-3.75
0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
- -
-0.03
-0.29
-3.52
-0.19
-0.59
-0.02
-0.68
-0.2
0.13
-1.03
-0.5
0.24
- -
0.89
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
0.58
0.72
0.59
0.54
0.52
0.5
0.52
0.58
0.57
0.67
0.7
0.7
- -
0.69
Dividend per Share
17.45
1.5
0.65
-2.2
-3.29
-6.84
-6.99
-8.56
-9.43
-8.31
-8.62
-9.29
-9.41
- -
-9.1
Book Value per Share
17.45
18.05
17.05
14.05
12.73
10.28
10.3
8.08
6.84
7.71
7.45
6.87
6.97
- -
7.1
Tangible Book Value per Share
8
9
9
9
9
9
9
10
10
10
10
10
10
- -
10
Basic Weighted Avg Shares
- -
2
-2
-33
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
-3
-31
-2
-5
- -
-7
-2
1
-10
-5
2
9
9
Net Income, GAAP
- -
116.49
- -
- -
2,670.15
- -
110.91
- -
- -
- -
- -
- -
2.25
- -
- -
Effective Tax Rate (%)
- -
-16.49
110.58
93.82
-2,570.15
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
-1
-3
-2
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
140
158
151
125
115
94
96
77
66
76
74
68
70
70
71
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-0.37
-26.61
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
10
10
10
Market Capitalization
95
105
109

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
2
2
2
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
2
2
2
Payables & Accruals
- -
- -
2
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-5.16%
1.28%
0.41%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
258.57%
-208.44%
249.53%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
3.18%
4.73%
-0.16%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.11
0.12
0.21
-0.2
0.24
2025
0.17
0.26
0.15
0.26
- -
2026
0.22
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.18
0.17
0.17
0.17
0.7
2025
0.17
0.17
0.17
0.17
- -
2026
0.17
- -
- -
- -
- -
Business
KP Tissue Inc. KP Tissue Inc. (TSX: KPT) operates as a holding company that holds a minority equity interest, currently approximately 12.1%, in Kruger Products Inc., Canada's leading manufacturer and marketer of disposable tissue products by market share; Kruger Products produces, distributes, markets and sells bathroom tissue, facial tissue, paper towels and napkins for the consumer and away-from-home markets across North America. Its consumer segment offers branded products including Cashmere, Purex, SpongeTowels, Scotties, Bonterra, White Swan and White Cloud, alongside premium private label offerings, while the away-from-home segment provides brands such as Esteem, Embassy, Satinelle, Chalet and additional private labels to commercial customers in industries like food services, property management, healthcare, manufacturing, education and lodging. Kruger Products operates ten FSC-certified production facilities, including four tissue plants and one in British Columbia with combined annual capacity of about 350,000 metric tonnes representing 44% of Canada's tissue production, plus a U.S. Memphis facility featuring a 55,000 metric tonne through-air-dry machine and initial 30,000 metric tonne operations through its wholly-owned subsidiary KTG; the company employs around 3,000 people and is headquartered in Mississauga, Ontario, with Kruger Inc., founded in 1904, holding the remaining majority interest. Recent developments include the successful startup of its state-of-the-art Sherbrooke, Quebec tissue plant equipped with advanced through-air-dry technology, an ongoing evaluation as of late 2024 to advance construction of a new greenfield tissue plant with a modern TAD machine and three converting lines to address rising competition in the ultra-premium segment and support expansion, a USD 35 million investment announced in 2025 for a new multi-purpose converting line at the Memphis facility set for 2026 startup, shutdown of older unprofitable assets including a paper machine and facial line, consolidation of area warehouses into a modern on-site Memphis facility to focus on higher-margin premium products, and divestitures such as the Clearwater and Royal operations to streamline U.S. operations.

Company News

APIChat
  • Independent Proxy Advisory Firms ISS and Glass Lewis Recommend KP Tissue Inc. Shareholders Vote "FOR" on all Resolutions at the Upcoming 2026 Annual Meeting of Shareholders

  • KP Tissue Announces Filing and Mailing of the Management Proxy Materials in Connection with Its 2026 Annual Meeting of Shareholders

  • KP Tissue Q1 Earnings Call Highlights

  • KP Tissue Inc. (KPT:CA) Q1 2026 Earnings Call Transcript

  • KP Tissue Increases Quarterly Dividend to $0.21 per Common Share Due to the Change in Tax Designation

  • RETRANSMISSION: KP Tissue to Release its Financial Results and Those of Kruger Products Inc. for the First Quarter of 2026

  • KP Tissue to Release its Financial Results and Those of Kruger Products Inc. For the First Quarter of 2026

  • KP Tissue (OTCMKTS:KPTSF) Stock Price Down 0.7% – What’s Next?

  • KP Tissue Inc. (KPT:CA) Q4 2025 Earnings Call Transcript

  • KP Tissue declares a Quarterly Dividend of $0.18 per Common Share

  • REPEAT - KP Tissue to Release its Financial Results and those of Kruger Products Inc. for the Fourth Quarter of 2025

  • Kruger Products Prices Senior Unsecured Notes

  • KP Tissue Inc. (KPT:CA) Q3 2025 Earnings Call Transcript

  • KP Tissue Releases Third Quarter 2025 Financial Results

  • KP Tissue to Release Its Financial Results and those of Kruger Products Inc. for the Third Quarter of 2025

  • KP Tissue Inc. (KPTSF) Q2 2025 Earnings Call Transcript

  • REPEAT: KP Tissue to Release its Financial Results and those of Kruger Products Inc. for the Second Quarter of 2025

  • KP Tissue to Release its Financial Results and those of Kruger Products Inc. for the Second Quarter of 2025

  • KP Tissue Inc. Reports on Shareholders' Voting Results for the Election of Directors

  • KP Tissue Announces Its Annual Meeting of Shareholders